Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer
Olivia K. Provance, Joan Lewis-Wambi
Breast Cancer Research (2019) Vol. 21, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Inflammation-Induced Tumorigenesis and Metastasis
Sana Hibino, Tetsuro Kawazoe, Hidenori Kasahara, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5421-5421
Open Access | Times Cited: 149
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Ugo Testa, Germana Castelli, Elvira Pelosi
Medical Sciences (2020) Vol. 8, Iss. 1, pp. 18-18
Open Access | Times Cited: 148
Breast cancer in the era of integrating “Omics” approaches
Cláudia Rossi, Ilaria Cicalini, Maria Concetta Cufaro, et al.
Oncogenesis (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 36
Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy
Chenghui Wu, Shuwen Dong, Renhong Huang, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 726-726
Open Access | Times Cited: 24
Unveiling the Link Between Chronic Inflammation and Cancer
Siddhant Tripathi, Yashika Sharma, Dileep Kumar
Metabolism Open (2025) Vol. 25, pp. 100347-100347
Open Access
IFITM protein regulation and functions: Far beyond the fight against viruses
Nela Friedlová, Filip Kokáš, Ted R. Hupp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Exploring neutrophil functionality in breast cancer progression: A review
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu
Medicine (2024) Vol. 103, Iss. 13, pp. e37654-e37654
Open Access | Times Cited: 4
The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway
Laura Martín-Hijano, Bruno Sáinz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 42
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer
Michelle M. Williams, Nicole S. Spoelstra, Spencer Arnesen, et al.
Cancer Research (2020) Vol. 81, Iss. 3, pp. 732-746
Open Access | Times Cited: 41
Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response
Hyeongjwa Choi, Juntae Kwon, Min Soon Cho, et al.
Cancer Research (2021) Vol. 81, Iss. 13, pp. 3607-3620
Open Access | Times Cited: 31
Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer
Tania Rossi, Giulia Gallerani, Davide Angeli, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2490-2490
Open Access | Times Cited: 32
Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma
Hideyuki Takahashi, Reika Kawabata‐Iwakawa, Shota Ida, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells
Evan R. Abt, Thuc Le, Amanda M. Dann, et al.
Cell Reports (2022) Vol. 38, Iss. 2, pp. 110236-110236
Open Access | Times Cited: 19
Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets
Chiara Romani, Eliana Bignotti, Davide Mattavelli, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2527-2527
Open Access | Times Cited: 23
Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy
Vladimir Rogovskii
Current Cancer Drug Targets (2024) Vol. 24, Iss. 11, pp. 1089-1103
Closed Access | Times Cited: 2
SADS-CoV nsp1 inhibits the STAT1 phosphorylation by promoting K11/K48-linked polyubiquitination of JAK1 and blocks the STAT1 acetylation by degrading CBP
Yingjie Xiang, Chunxiao Mou, Liqi Zhu, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 3, pp. 105779-105779
Open Access | Times Cited: 2
Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis
Dingxie Liu, Jaydutt V. Vadgama, Yong Wu
International Journal of Biological Sciences (2021) Vol. 17, Iss. 3, pp. 670-682
Open Access | Times Cited: 21
Disrupting interferon-alpha and NF-kappaB crosstalk suppresses IFITM1 expression attenuating triple-negative breast cancer progression
Olivia K. Provance, Eric S. Geanes, Asona J. Lui, et al.
Cancer Letters (2021) Vol. 514, pp. 12-29
Open Access | Times Cited: 20
HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy
Jie Wang, Feng Yun, Jiahui Sui, et al.
Biomedicines (2022) Vol. 11, Iss. 1, pp. 88-88
Open Access | Times Cited: 14
Non-histone substrates of histone deacetylases as potential therapeutic targets in epilepsy
Sonali Kumar, Diksha Attrish, Arpna Srivastava, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 25, Iss. 1, pp. 75-85
Closed Access | Times Cited: 22
Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression
Jesse D. Armitage, Hannah V. Newnes, Alison M. McDonnell, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 56-56
Open Access | Times Cited: 19
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer
Natalia Partain, Lauren M. Postlewait, Mediget Teshome, et al.
Annals of Surgical Oncology (2021) Vol. 28, Iss. 8, pp. 4265-4274
Closed Access | Times Cited: 19
Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer
Na‐Lee Ka, Ga Young Lim, Seung‐Su Kim, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 12
Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
Ariane Steindl, Donát Alpár, Gerwin Heller, et al.
ESMO Open (2021) Vol. 6, Iss. 2, pp. 100057-100057
Open Access | Times Cited: 16
Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
Yanqi Ye, C. F. Xu, Fengqian Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top